Drug Profile
Nesbuvir
Alternative Names: HCV-796; VP 19796Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator ViroPharma
- Developer ViroPharma; Wyeth
- Class Antivirals; Benzofurans; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 16 Apr 2008 Discontinued - Phase-I for Hepatitis C in Japan (PO)
- 16 Apr 2008 Discontinued - Phase-II for Hepatitis C in USA (PO)